Doloromics

Menlo Park, United States

Capitalizing on our human data-guided target identification and validation platform, we are redefining the landscape of pain management.

$6.7M raised

Feb 2022

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Doloromics raised?

Doloromics has raised $6.7M in total funding. The most recent round was Seed. The last funding was announced in February 2022.

Who are Doloromics's investors?

Doloromics's investors include Mayfield Fund, Illumina Accelerator.

Where is Doloromics headquartered?

Doloromics is headquartered in Menlo Park, United States.

What does Doloromics do?

Capitalizing on our human data-guided target identification and validation platform, we are redefining the landscape of pain management.

What stage is Doloromics at?

Doloromics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 1, 2022.

MLA

"Doloromics — Funding & Investors." VCBacked, February 1, 2022, https://www.vcbacked.co/company/doloromics. Accessed July 2, 2026.

APA

VCBacked. (2022). Doloromics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/doloromics

Wikipedia (cite web)

{{cite web |title=Doloromics — Funding & Investors |url=https://www.vcbacked.co/company/doloromics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 1, 2022.